Brookdale Senior Living Tops Zacks Rank #1 with 156% Gain, 34.1% Growth Outlook
Brookdale Senior Living holds Zacks Rank #1 in the Medical sector with a projected long-term earnings growth rate of 34.1% and a 156.2% share gain over the past year. Among Zacks #1 stocks, Brookdale outpaced peers BrightSpring Health (138.9% gain) and Catalyst Pharmaceuticals (10.7% gain), underscoring its sector leadership.
1. Zacks Rank #1 Placement
Brookdale Senior Living secured a top-tier ranking in the Medical sector, reflecting analysts’ assessment of its strong operating fundamentals and senior care market positioning.
2. Long-Term Growth Outlook
Equity analysts project a 34.1% compound annual growth rate in Brookdale’s earnings, driven by aging demographics and expanding occupancy in its senior living communities.
3. Share Performance Comparison
The stock delivered a 156.2% total return over the past 12 months, outstripping peer BrightSpring Health’s 138.9% gain and significantly outperforming Catalyst Pharmaceuticals’ 10.7% increase.
4. Future Performance Drivers
Key factors influencing Brookdale’s outlook include occupancy rates, reimbursement policy changes, and management’s ability to control operating costs in its care facilities.